CO
COR
Stock Cencora Inc.Methodology breakdown computing — it will appear here on its own.
Cencora Inc. (COR) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for COR — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | $10M | 0.0% | 2026-06-30 |
| Azzad Asset Management | Azzad Asset Management | $2M | 0.2% | 2026-06-30 |
| Wahed Invest | Wahed Invest LLC | $1M | 0.1% | 2026-06-30 |
| Ken Fisher | Fisher Asset Management | $1M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 50.40 | NEUTRAL |
| Stochastic %K (14) | 18.61 | BUY |
| CCI (20) | -19.67 | NEUTRAL |
| Williams %R (14) | -81.39 | BUY |
| MACD (12,26,9) | -1.31 | SELL |
| ROC (10) | 0.11 | BUY |
| Momentum (10) | 0.34 | BUY |
| EMA (10) | 325.04 | SELL |
| SMA (10) | 327.17 | SELL |
| EMA (20) | 323.23 | SELL |
| SMA (20) | 323.24 | SELL |
| EMA (30) | 320.24 | BUY |
| SMA (30) | 321.01 | BUY |
| EMA (50) | 314.79 | BUY |
| SMA (50) | 314.77 | BUY |
| EMA (100) | 310.53 | BUY |
| SMA (100) | 296.79 | BUY |
| EMA (200) | 319.83 | BUY |
| SMA (200) | 319.95 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
About Cencora Inc.
Healthcare · Medical Distribution
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-09-10
🟡 BULLISH LEAN
The main driver: RSI in healthy zone, Wall Street broadly bullish, insiders buying with real money. More signals pointing up than down. Not full confluence yet, but the weight of evidence is bullish. Use `!alert COR [level]` to catch the entry, or `!plan COR` to size small.
Scores: 3 bullish / 1 bearish
Average — needs more confirmation before sizing up
SMC — Top Down
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 62 |
| ⏰ 4H | RANGING | 38 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BULLISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Peer Movement
Peer movement computing — it will appear here on its own.
Insider Activity (90d)
BULLISH 2 buys · 1 sells
Recent: Campbell Elizabeth S sold 19455 sh @ $324.12 (2026-08-24)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.